Flynn Kevin J, Erickson Bradley A, Guidos Paul J, Simmering Jacob, Polgreen Philip, Tracy Chad R
Department of Urology, University of Iowa, Iowa City, Iowa.
Department of Internal Medicine, University of Iowa, Iowa City, Iowa.
Urol Pract. 2019 Nov;6(6):369-376. doi: 10.1097/UPJ.0000000000000056. Epub 2019 Oct 23.
We identified patterns of postoperative pain and opioid consumption and associated factors following ureteroscopy for kidney stones by acquiring real-time data through automated text messages.
Adult patients undergoing ureteroscopy for kidney stones were prospectively enrolled to receive postoperative pain assessments and opioid consumption inquiries through daily automated text messages. Patients were prompted for pain levels (0 to 10) twice daily and opioid consumption nightly. Univariable and multivariable analyses were performed to identify factors associated with decreased time to pain resolution and increased opioid consumption.
Of 62 patients enrolled 46 (74%) completed the study. Median time to pain resolution was 7 days and 75% of patients reported pain of 4 or less by postoperative day 3. Median opioid consumption was 10 pills, 25% of patients consumed no pills and 63% of pills went unused. Higher pain immediately preceding surgery (HR 0.7, p <0.001) and preoperative opioid consumption (HR 0.36, p=0.004) were predictive of increased time to pain resolution. Increased postoperative opioid consumption was associated with increased pain immediately preceding surgery (p <0.001), consumption of opioids at the time of surgery (p=0.001) and increased quantity of opioid consumption at the time of surgery (p <0.001). Preoperative renal drainage was associated with faster pain resolution (HR 2.29, p=0.017) and decreased opioid use (p=0.018).
Pain following ureteroscopy peaks on postoperative day 0 and decreases to zero by postoperative day 7, with patients taking a median of 10 opioids in the postoperative period. Preoperative identification of at-risk populations allows for patient specific dose escalation of opioids, which may limit future opioid overprescription.
我们通过自动短信获取实时数据,确定了输尿管镜取肾结石术后的疼痛模式、阿片类药物消耗情况及相关因素。
前瞻性纳入接受输尿管镜取肾结石手术的成年患者,通过每日自动短信接受术后疼痛评估和阿片类药物消耗询问。每天提示患者两次疼痛程度(0至10级),每晚询问阿片类药物消耗情况。进行单变量和多变量分析,以确定与疼痛缓解时间缩短和阿片类药物消耗增加相关的因素。
62例纳入研究的患者中,46例(74%)完成了研究。疼痛缓解的中位时间为7天,75%的患者在术后第3天报告疼痛为4级或更低。阿片类药物消耗的中位数为10片,25%的患者未服用药物,63%的药物未被使用。手术前即刻疼痛程度较高(HR 0.7,p<0.001)和术前阿片类药物消耗(HR 0.36,p = 0.004)可预测疼痛缓解时间延长。术后阿片类药物消耗增加与手术前即刻疼痛加剧(p<0.001)、手术时服用阿片类药物(p = 0.001)以及手术时阿片类药物服用量增加(p<0.001)有关。术前肾引流与疼痛缓解更快(HR 2.29,p = 0.017)和阿片类药物使用减少(p = 0.018)有关。
输尿管镜检查术后疼痛在术后第0天达到峰值,术后第7天降至零,患者术后阿片类药物消耗中位数为10片。术前识别高危人群有助于根据患者具体情况增加阿片类药物剂量,这可能会限制未来阿片类药物的过度处方。